Rc. Semelka et al., Malignant hepatic tumors: Changes on MRI after hepatic arterial chemoembolization - Preliminary findings, J MAGN R I, 8(1), 1998, pp. 48-56
This study describes the MR appearances of malignant hypervascular liver le
sions pre- and post-hepatic-arterial chemoembolization, with correlation to
serial imaging and clinical responses, Eight patients with malignant hyper
vascular liver lesions underwent pretreatment and posttreatment MR examinat
ion on a 1.5-T MR imager. MR sequences included T1-weighted spoiled gradien
t echo (SGE), T2-weighted fat-suppressed spin echo or turbo spin echo, and
dynamic gadolinium-enhanced SGE images. AU patients underwent pretreatment,
initial posttreatment, and subsequent posttreatment MR studies, The histol
ogy of primary tumors included various types of hepatocellular carcinoma (H
CC) (four patients: fibrolamellar HCC [one patient], HCC [two patients], mi
xed HCC/cholangiocarcinoma [one patient]) and liver metastases (four patien
ts: untyped islet cell tumor [two patients], gastrinoma [one patient], carc
inoid [one patient]), Response to chemoembolization was determined by three
assessments: MR response, serial imaging response, and clinical response.
The appearance of MR response to chemoembolization was determined based on
the correlation with clinical and serial imaging response. The MR response
of lesions that showed good clinical response included: increase in signal
intensity on T1-weighted images (three patients), decrease in signal intens
ity on Ta-weighted images (three patients), and negligible or minimal enhan
cement on immediate postgadolinium images (four patients) after chemoemboli
zation, The most marked change in lesion appearance was observed in lesions
less than or equal to 1 cm, which had intense homogeneous enhancement on p
retreatment MR studies and negligible enhancement on initial posttreatment
MR examinations. MR response of lesions that showed moderate clinical respo
nse demonstrated a variety of lesion appearances from substantial change to
minimal change. MR response of lesions that showed poor clinical response
demonstrated no change in lesion appearances compared with the pretreatment
MR study. Our results demonstrated change in appearance of liver lesions b
etween pre- and post-hepatic-arterial chemoembolization MR studies. MR resp
onse correlated with response determined by serial imaging studies and clin
ical findings.